Home/Filings/4/0001562180-23-008250
4//SEC Filing

Krawtschuk Christopher 4

Accession 0001562180-23-008250

CIK 0001293971other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:42 PM ET

Size

9.0 KB

Accession

0001562180-23-008250

Insider Transaction Report

Form 4
Period: 2023-12-06
Krawtschuk Christopher
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2023-12-06$4.52/sh4,526$20,43745,474 total
Footnotes (2)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]The range in prices for the transaction reported on this line was $4.50 to $4.55. The average weighted price was $4.5155. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001952720

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:42 PM ET
Size
9.0 KB